Vitalhub (TSE:VHI) Given New C$12.50 Price Target at Canaccord Genuity Group

Vitalhub (TSE:VHI) had its target price hoisted by Canaccord Genuity Group from C$12.00 to C$12.50 in a research report released on Thursday,BayStreet.CA reports. They currently have a buy rating on the stock.

VHI has been the subject of a number of other reports. Cormark lifted their target price on Vitalhub from C$9.50 to C$10.50 and gave the company a “buy” rating in a research note on Wednesday, October 2nd. TD Securities upgraded shares of Vitalhub to a “strong-buy” rating in a report on Monday, November 25th. Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of C$10.05.

Vitalhub Stock Performance

Vitalhub stock opened at C$10.95 on Thursday. Vitalhub has a 1 year low of C$4.00 and a 1 year high of C$12.09. The firm’s 50-day moving average is C$11.11 and its 200-day moving average is C$9.35. The company has a market cap of C$556.81 million, a P/E ratio of 99.55, a PEG ratio of 1.18 and a beta of 1.26.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.